AI news impact · China A-shares
Guangzhou Kingmed Diagnostics Group Co. Ltd. Class A (603882) news impact
On 2026-10-30 Wave Radar's AI rated the news on Guangzhou Kingmed Diagnostics Group Co. Ltd. Class A as major positive (impact score +85%).
KingMed reported Q3 net profit surged 3,427.94% YoY to 183 million yuan; 9M profit reached 374 million yuan with a proposed 10 yuan dividend per 10 shares.
- Direction
- Major positive
- Impact score
- +85%
- Confidence
- 90%
- Headlines read
- 3
- Flags
- Industry risk
- Date
- 2026-10-30
AI assessment
Explosive single-quarter net profit surge over 34x alongside generous dividend distribution signals a strong operational turnaround.
Sector impact
As a leading independent medical lab, its robust rebound bolsters market sentiment for the IVD and medical testing sector.
Headlines the AI read
- 金域医学:2026年前三季度盈利3.74亿元 拟10派10元 AkShare/中国证券报·中证网 · 2026-10-28
- 金域医学2026年第三季度归母净利润1.83亿元 同比增长3427.94% AkShare/央广财经 · 2026-10-28
- 【数据揭秘】融资客看好个股一览 AkShare/证券时报网 · 2026-10-21
Rating history
One rating per trading day the stock was covered.
More on Guangzhou Kingmed Diagnostics Group Co. Ltd. Class A
How the rating works
After each close Wave Radar collects the day's headlines and filings for a stock and asks an AI model what they mean for it. The rating is one of five levels from major negative to major positive; the impact score runs from −100% to +100%, and a rating built on a single uncorroborated source is capped. It describes the news, not the price outlook.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.